Archive:
How much has life expectancy increased, and how much have health limitations decreased during this longer lifespan? This question is explored in the study entitled "Development of Health Benefits," commissioned by the Federation of German Industries (BDI). It was conducted by the IGES Institute, WifOR GmbH, and Bielefeld University. The study examines the period from 1993 to 2013 for five selected diseases.
24.07.2017
Antibiotics for the treatment of infectious diseases caused by bacteria are among the most important advances in medicine. However, the different points of attack of these drugs and their sensible use depending on the severity of the infection make selecting the right active ingredient a challenge. However, careful consideration of the benefits and correct intake have a significant influence on the success of the therapy and ultimately on the avoidance of resistance. This issue is increasingly exacerbated by multi-resistant bacterial strains and a small number of newly approved antibiotics. This article highlights how the use of antibiotics has developed in recent years and what measures are being taken to ensure needs-based supply.
24.07.2017
If there can be a second speaker and lecturer in the German health care system alongside Josef Hecken, who was elected professor by the Saarland in recognition of his achievements in science and research, who can take on this task with equally exquisite expertise in terms of content and humor, it is Dr. med. Wolfgang Hoffmann, MPH, also a full W3 professor and this year also President of the German Congress of Health Services Research (DKVF). “Monitor Health Care Research” spoke to him about the goals and structure of the Central Congress of German Health Care Research, which is now taking place for the 16th time and which – as Hoffmann says – once again, but somewhat stronger than in previous years, bridges the gap between “scientificity and relevance to health care”. want to beat.
24.07.2017
Die nächste medizinische Revolution wird kein Medikament sein, nicht einmal aus extra dafür neu programmierten Bites und Bytes bestehen, sondern sich aus der klugen, sicheren und sinnstiftenden Zusammenführung und Nutzung bestehender Daten entwickeln. Damit ließen sich Prognosen über die gesundheitliche Entwicklung eines Patienten machen, sofern er dies wünscht und zulässt. Damit könnte man zum Beispiel ebenso abschätzen, wie hoch das Risiko eines an Diabetes erkrankten Menschen ist, in den kommenden 12 Monaten ins Krankenhaus zu müssen. Und telemedizinische Modelle könnten helfen, die Versorgung im ländlichen Raum, wo es nicht mehr genug Ärzte gibt, auch weiterhin sicherzustellen.
24.07.2017
The Department of Health Services Management was founded in 2013 at Ludwig Maximilian University of Munich (LMU). Currently, in addition to the head, Prof. Dr. Leonie Sundmacher, the department employs seven research associates, a team assistant, and student assistants. The empirically oriented research at the Department of Health Services Management (HSM) focuses on questions and methods at the intersection of health economics and health services research. The research conducted at the HSM department is always applied and largely takes place in collaboration with various stakeholders in the healthcare sector. Furthermore, the department is located within the Munich Center for Health Sciences and is thus part of an interdisciplinary, cross-faculty research focus at LMU.
24.07.2017
At Vitabook, patients can already create their own health account, which is designed to function as easily as a checking account and which, after patient approval, makes the data it contains available to doctors, clinics, pharmacies, health insurance companies, laboratories, billing agencies, nursing services, and medical supply stores. The company, which describes itself as Germany's first patient service provider, already offers electronic prescriptions, an online medication plan, an online vaccination record, online submission of medical bills, discharge management, and, to top it all off, an implant registry. "Monitor Versorgungsforschung" spoke with Vitabook founder (and new MVF advisory board member) Markus Bönig about the background and the resulting opportunities for health services research.
24.07.2017
„A functioning governance structure is the crucial prerequisite for the successful nationwide implementation of eEPA systems,“ writes Prof. Dr. Peter Haas, author of the study „Cross-institutional Electronic Patient Records as a Basis for Integrated Patient-Centered Treatment Management Platforms,“ commissioned by the Bertelsmann Foundation in mid-2017, and thus presents a ten-year timetable for a phased concept for the introduction of a nationwide, cross-institutional electronic patient record infrastructure, or eEPA for short. Such a cross-institutional patient record would certainly be an important and necessary undertaking, but its complexity and comprehensiveness are somewhat reminiscent of the dark early years of the telematics infrastructure in Germany. Besides the sheer feasibility and implementation of such a large-scale approach, it also faces a slight time constraint: Section 291a, Paragraph 5c of the German Social Code, Book V (SGB V), which regulates the "Electronic Health Card and Telematics Infrastructure," states verbatim that "the necessary conditions must be created by December 31, 2018, so that data about the patient can be made available in an electronic patient record." With a few exceptions, however, this remains a distant prospect.
24.07.2017
What strategy can the healthcare system use to meet future challenges such as demographic change and the increase in widespread and multiple diseases? The "Value Chain" working group of the Forum for Health Research addressed this question in a recommendation for the Federal Ministry of Education and Research (BMBF). The focus of their work was on the obstacles along the value chain in health research. To overcome these obstacles, the working group recommends two things: First, the validity and quality of basic biomedical research should be improved. Second, the working group advocates for a translational program that accelerates the introduction of new drugs and helps innovations achieve a breakthrough.
24.07.2017
Tumor diseases represent one of the world's greatest medical challenges. According to vfa, a quarter of all pharmaceutical companies' projects currently relate to drugs to improve cancer therapy. With the help of the INSIGHT Health patent database SHARK, a look is taken at the innovative oncologic drugs in the pipelines of the pharmaceutical industry. The focus is on substances that are in phase III and in approval (preregistered).
24.07.2017
Dr. med. Konrad Schily comes from an anthroposophical family. He studied medicine in Tübingen and Hamburg and opened the community hospital in Herdecke with other doctors in 1969, where he served on the board until 1984. He is the co-founder of the University of Witten/Herdecke, which opened in 1983 to study medicine and has taken completely new paths in the training of doctors in Germany. It was also the University of Witten/Herdecke that first established courses in nursing sciences - combined with the right to award doctorates. After leaving the Bundestag (2005 to 2009), he has been committed to founding and developing the Brandenburg Medical School (MHB) in recent years and is once again breaking new ground here. Also because the neurology and psychiatry specialist knows from his own experience that “really good doctors in our healthcare system suffer, as do the patients.”